Skip to main content
. 2003 Mar;162(3):737–746. doi: 10.1016/S0002-9440(10)63870-9

Table 2.

Clinical Outcome in Patients with Pediatric Urticaria Pigmentosa (Only Patients with Follow-Up of 12 to 20 Years Included)

n Mean follow-up, years Activating c-kit mutations
Persistent UP 11* 15.4 4/11 (36.4%)
Transient UP 9 15.2 4/9 (44.4%)
Total 20 15.3 8/20 (40.0%)

*Including one patient with marked improvement of the disease.